Australia markets closed

BioGaia AB (publ) (BIOGY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
12.090.00 (0.00%)
At close: 11:51AM EDT

BioGaia AB (publ)

Kungsbroplan 3
Stockholm
Sweden
46 8 555 293 00
https://www.biogaia.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees210

Key executives

NameTitlePayExercisedYear born
Mr. Peter Rothschild M.Sc. Econ., MBAFounder & Chairman1.3MN/A1950
Mr. Alexander Kotsinas M.Sc. (Eng.).Executive VP & CFO2.98MN/A1967
Ms. Theresa P. AgnewCEO & PresidentN/AN/A1966
Ludvig MilessonChief Operating OfficerN/AN/A1977
Mr. Gianfranco GromponeChief Scientific Officer and VP of Research & DevelopmentN/AN/A1975
Ms. Caroline MoforsChief Legal OfficerN/AN/A1972
Ms. Linda HagglundVice President of MarketingN/AN/A1973
Ms. Angelika KjelldorffChief HR OfficerN/AN/A1969
Sebastian HeimforsVP & Chief Commercial OfficerN/AN/A1974
Jonathan GromarkSustainability ManagerN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.

Corporate governance

BioGaia AB (publ)’s ISS governance QualityScore as of 1 March 2024 is 9. The pillar scores are Audit: 9; Board: 7; Shareholder rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.